nafamostat and apilimod

nafamostat has been researched along with apilimod in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Balistreri, G; Kirchhausen, T; Kreutzberger, AJB; Ojha, R; Pyle, JD; Sanyal, A; Vapalahti, O1

Other Studies

2 other study(ies) available for nafamostat and apilimod

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease.
    Journal of virology, 2021, 10-13, Volume: 95, Issue:21

    Topics: Animals; Antiviral Agents; Benzamidines; Cell Line, Tumor; Chlorocebus aethiops; COVID-19 Drug Treatment; Drug Synergism; Esters; Guanidines; Humans; Hydrazones; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protease Inhibitors; Pyrimidines; SARS-CoV-2; Serine Endopeptidases; Vero Cells; Virus Internalization

2021